May 3 Earnings Announcement Location 106 Charles Lindbergh Blvd. Independently, and with its corporate partners, the Company has built a pipeline of discovery programs and drug candidates for 46 individual gene targets, addressing major, unmet clinical needs and significant commercial opportunities. The Company has two candidates in clinical trials and nine projects with candidates in late stage pre-clinical development. Net loss before acct.
Revenues reflect lower technology access fees.
Market Guide offers more in-depth Company Research , Stock Screening , and Hottest Stocks and Industries on over 10,000 U.S. Equities. All Rights Reserved. Privacy Policy - Terms of Service Company information Copyright Market Guide . Event data provided by StreetEvents . Data and information is provided for informational purposes only, and is not intended for trading purposes.